In vitro testing of Innovation Pharmasﾒ Brilacidin for COVID-19 showed consistent anti-SARS-CoV-2 efficacy
On Jul. 7, 2020, Innovation Pharma reported the latest developments related to research into Brilacidin as a potential…
-
-
Novavax announced $1.6 billion funding from Operation Warp Speed
On Jul. 7, 2020, Novavax announced that it had been selected to participate in Operation Warp Speed, a…
-
LabCorp lanuched first digital COVID-19 service that improves the doctor and patient experience
On Jul. 7, 2020, LabCorpﾮ launched the LabCorp At Home COVID-19 Test Collection Service, the first seamless digital…
-
Regeneron announced manufacturing and supply agreement for BARDA and U.S. DoD for REGN-COV2 anti-viral antibody cocktail
On Jul. 7, 2020, Regeneron announced that, as part of Operation Warp Speed, the Biomedical Advanced Research and…
-
Corvus Pharmaceuticals initiated clinical trial of novel immunotherapy for patients with COVID-19
On Jul. 7, 2020, Corvus Pharmaceuticals announced that it has initiated a Phase 1 study to investigate a…
-
Tonix Pharma announced plans for Massachusetts R&D facility to accelerate clinical development of vaccines and protein-based therapeutics
On Jul. 7, 2020, Tonix Pharmaceuticals announced its intent to purchase an approximately 40,000 square foot facility in…
-
Merck announced analyses showing additional safety and efficacy data for investigational Islatravir in combination with Doravirine in adults with HIV-1 infection
On Jul. 6, 2020, Merck announced a new analyses from the Phase 2b trial evaluating the safety and…
-
The FDA issued an emergency use authorization for the third diagnostic test for detection and differentiation of the viruses that cause flu and COVID-19
On Jul. 6, 2020, the FDA issued an emergency use authorization (EUA) for the third diagnostic test for…
-
The FDA approved Qwo (collagenase clostridium histolyticum-aaes), the first injectable treatment for cellulite
On Jul. 6, 2020, Endo International announced that it received FDA approval of Qwo (collagenase clostridium histolyticum-aaes) for…
-
Ignoring airborne COVID spread risky
On Jul. 6, 2020, the lack of universal recognition that COVID-19 is transmitted via airborne particles, along with…
-
Sinovac COVID-19 vaccine collaboration with Butantan received approval from Brazilian regulator for phase III trial
On Jul. 6, 2020, Sinovac Biotech announced that on Jul. 3, 2020, the Brazilian National Regulatory Agency, Anvisa,…
-
Immune Regulation partnered with DynPort Vaccine to advance drug product for COVID-19 into clinical trials
On Jul. 9, 2020, Altimmune announced that it had entered into a teaming agreement with DynPort Vaccine Company…
-
Emergent BioSolutions signed five-year agreement for large-scale drug substance manufacturing for Johnson & Johnsonﾒs COVID-19 vaccine candidate
On Jul. 6, 2020, Emergent BioSolutions announced a five-year manufacturing services agreement with Janssen Pharmaceuticals, a Johnson &…
-
Anixa Biosciences and OntoChem announced completion of initial screening program and identification of additional Covid-19 compounds
On Jul. 6, 2020, Anixa Biosciences announced that it and partner OntoChem had completed the initial in silico…
-
AIM ImmunoTech signed material transfer and research agreement with Japan’s National Institute of Infectious Diseases and Shionogi & Co to test Ampligen as potential vaccine adjuvant for COVID-19
On Jul. 6, 2020, AIM ImmunoTech announced that it had signed a material transfer and research agreement with…
-
ADMA Biologics opened its newest ADMA BioCenters plasma collection facility
On Jul. 6, 2020, ADMA Biologics announced the commencement of operations and initiation of collections at its newest…
-
COVID-19 | Diagnostics | FDA
BD launched portable, rapid point-of-care antigen test to detect SARS-CoV-2 in 15 minutes, expanding access to COVID-19 testing
On Jul. 6, 2020, BD (Becton, Dickinson) announced the U.S. Food and Drug Administration (FDA) had granted Emergency…
-
Regeneron announced start of REGN-COV2 phase 3 COVID-19 prevention trial in collaboration with National Institute of Allergy and Infectious Diseases
On Jul. 6, 2020, Regeneron announced initiation of late-stage clinical trials evaluating REGN-COV2, Regeneron’s investigational double antibody cocktail…
-
Todos Medical announced nationwide on-site Coronavirus testing program
On Jul. 6, 2020, Meridian HSN announced it had partnered with Moto-Para and Todos Medical to provide a…
-
Mylan secured regulatory approval for remdesivir lyophilized powder for injection 100 mg/vial in India for restricted emergency use in COVID-19 patients
On Jul. 6, 2020, Mylan announced that the Drug Controller General of India (DCGI) has approved its remdesivir…
-
WHO discontinued hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19
On Jul. 4, 2020, the World Health Organization (WHO) accepted the recommendation from the Solidarity Trial’s International Steering…
-
EC granted conditional Marketing Authorization for Gileadﾒs Vekluryﾮ (remdesivir) for treatment of COVID-19
On Jul. 3, 2020, Gilead Sciences announced the European Commission had granted conditional marketing authorization for Vekluryﾮ (remdesivir)…
-
CytoDyn announced exclusive agreement for distribution and supply of leronlimab for treatment of COVID-19 in U.S.
On Jul. 3, 2020, CytoDyn announced it had signed an exclusive Distribution and Supply Agreement with American Regent…
-
Abivax treated first patient in phase 2b/3 ABX464 Covid-19 clinical trial
On Jul. 2, 2020, Abivax announced that the first patient has been treated in its Phase 2b/3 study…
-
Biotechnology | FDA | HIV | Therapeutics
The FDA approved new HIV treatment for patients with limited treatment options
On Jul. 2, 2020, the U.S. Food and Drug Administration (FDA) approved Rukobia (fostemsavir), a new type of…
-
CDC announced action to prepare against ‘G4’ swine flu viruses in China with pandemic potential
On Jul. 2, 2020, the U.S. Centers for Disease Control and Prevention (CDC) announced a publication in the…
-
COVID-19 | Diagnostics | FDA | Medical Device
FDA issued Emergency Use Authorization for Philips’ acute care patient monitoring solutions for hospitals
On Jul. 2, 2020, Royal Philips announced that the FDA had issued an Emergency Use Authorization (EUA) for…
-
TGen teamed with Poba Medical to produce 10,000 COVID-19 test kits per month
On Jul. 2, 2020, in response to the continuing need for more COVID-19 diagnostic tests, the Translational Genomics…
-
ViiV Healthcare announced FDA approval for Rukobia (fostemsavir), a first-in-class treatment for HIV in adults
On Jul. 2, 2020, ViiV Healthcare, a GSK company, with Pfizer and Shionogi Limited, announced the FDA had…
-
Regeneron and Sanofi announced Kevzara (sarilumab) phase 3 US trial in COVID-19 patients did not meet endpoints
On Jul. 2, 2020, Regeneron and Sanofi announced that the U.S. Phase 3 trial of Kevzara (sarilumab) 400…
